Showing 1491-1500 of 7140 results for "".
Cosmeceutical Advances in 2016
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/cosmeceutical-advances-in-2016/18622/Suneel Chilukuri, MD discusses recent advances in the cosmeceutical market including a new topical formulated to protect the skin from UVA/UVB damage as well as from infrared radiation, a skin brightening topical formulated to carry retinol deeper into the skin, and a topical hyaluronic acid productPearls for Injectables: From Toxins to Fillers
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/pearls-for-injectables-from-toxins-to-fillers/18628/Ava Shamban, MD shares her rationale for thinking of the face in three treatment areas for rejuvenation procedures—upper, middle, and lower. Devising strategies with injections targeted to each area will help patients achieve more natural recountouring while achieving the youthful appearance they deThe Connected Consumer
https://practicaldermatology.com/topics/practice-management/the-connected-consumer/21050/To effectively and proactively market your practice, you must understand patients' needs, aspirations, preferences, and habits.Pediatric Atopic Dermatitis And Psoriasis
https://practicaldermatology.com/topics/psoriasis/pediatric-atopic-dermatitis-and-psoriasis/18631/Lawrence Eichenfield, MD provides an update on pediatric atopic dermatitis and psoriasis. Unfortunately, he said, many children remain undertreated for their eczema despite the availability of effective treatments and a number of topical and systemic products on the horizon. Dr. Eichenfield also proThe Rising Costs of Prescription Drugs
https://practicaldermatology.com/topics/practice-management/the-rising-costs-or-prescription-drugs/18677/What's really causing the costs of dermatology prescriptions, especially generics, to skyrocket? Jake Levitt, MD and Mark Lebwohl, MD speak to host Neal Bhatia, MD about what's influencing these rising costs, and who, if anyone, is benefiting. Dr. Levitt talks about the rebate system between manufacThe Future of Atopic Dermatitis Therapy
https://practicaldermatology.com/topics/general-topics/the-future-of-atopic-dermatitis-therapy/21143/As new research elucidates the individual mechanisms of atopic dermatitis, the development of therapies that more directly influence the disease may change the scope of treatment.Ask An Expert: Establishing Yourself as an Expert
https://practicaldermatology.com/topics/practice-management/ask-an-expert-establishing-yourself-as-an-expert/18937/In this edition of NewDermMD's video series, host Adam Friedman, MD speaks with Neal Bhatia, MD about establishing one's expertise, becoming an educator, and finding a comfortable place working with industry, peers, and societies. Whether your interest is in cosmetic dermatology, acne, psoriasis, peValeant Acquires Salix; Actavis Changing Name
https://practicaldermatology.com/series/dermwire-tv/valeant-acquires-salix-actavis-changing-name/18963/Valeant expands its portfolio with the acquisition of GI market leader Salix. Actavis divests Doryx and considers a name change to Allergan. Kythera acquires rights for investigational hair therapies. And Cynosure's 532nm laser delivery system is FDA cleared for PicoSure.Otezla Approved for Plaque Psoriasis
https://practicaldermatology.com/topics/psoriasis/dermiretv-otezla-approved-for-plaque-psoriasis/19031/In this week's edition of DermWireTV from the publishers of Practical Dermatology® magazine and DermWire.com, a look at Celgene's Otezla for psoriasis--the first PDE4 inhibitor approved for plaque psoriasis. Plus, Ranbaxy's new dosage strengths of Absorica (isotretinoin), and Galderma's search for pSecrets of Effective Communication
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/secrets-of-effective-communication/19085/Heidi Waldorf, MD, FAAD and Steven Dayan, MD, FACS, Co-Chief Medical Editors of Modern Aesthetics®magazine, share strategies for understanding patient needs, setting expectations, and building relationships.